# Venrock Adviser, LLC: Form 13F holdings

An institutional investment manager in NEW YORK, NY. SEC CIK 1615982.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $3.30bn
- Positions: 33 (33 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1615982/000161598226000015/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| APOGEE THERAPEUTICS INC | COM | $1.13bn | 34.2% | 8,493,321 |  | Unchanged |
| [ORUKA THERAPEUTICS INC (ORKA)](/companies/orka.md) | COM | $394.8m | 12.0% | 4,148,428 |  | Unchanged |
| [ERASCA INC (ERAS)](/companies/eras.md) | COM | $327.8m | 9.9% | 17,891,812 |  | Added +1,509,000 |
| [SPYRE THERAPEUTICS INC (SYRE)](/companies/syre.md) | COM NEW | $265.0m | 8.0% | 2,985,448 |  | Reduced −700,000 |
| [DIANTHUS THERAPEUTICS INC (DNTH)](/companies/dnth.md) | COM | $115.0m | 3.5% | 1,180,000 |  | Unchanged |
| [OCULAR THERAPEUTIX INC (OCUL)](/companies/ocul.md) | COM | $101.6m | 3.1% | 10,346,926 |  | Unchanged |
| DAMORA THERAPEUTICS INC | COM NEW | $93.7m | 2.8% | 3,603,595 |  | Unchanged |
| [SAVARA INC (SVRA)](/companies/svra.md) | COM | $90.8m | 2.8% | 14,745,943 |  | Added +1,005,568 |
| [JADE BIOSCIENCES INC (JBIO)](/companies/jbio.md) | COM NEW | $71.6m | 2.2% | 3,220,364 |  | Unchanged |
| [COGENT BIOSCIENCES INC (COGT)](/companies/cogt.md) | COM | $63.6m | 1.9% | 1,642,166 |  | Reduced −357,834 |
| [VIRIDIAN THERAPEUTICS INC (VRDN)](/companies/vrdn.md) | COM | $59.8m | 1.8% | 3,257,917 |  | Reduced −624,792 |
| [VOR BIOPHARMA INC (VOR)](/companies/vor.md) | COM NEW | $56.0m | 1.7% | 3,041,719 |  | Unchanged |
| [DYNE THERAPEUTICS INC (DYN)](/companies/dyn.md) | COM | $48.3m | 1.5% | 2,173,913 |  | Unchanged |
| [MAZE THERAPEUTICS INC (MAZE)](/companies/maze.md) | COM | $47.8m | 1.4% | 1,602,034 |  | Unchanged |
| [RELMADA THERAPEUTICS INC (RLMD)](/companies/rlmd.md) | COM | $47.4m | 1.4% | 6,844,305 |  | Added +2,000,925 |
| [ORIC PHARMACEUTICALS INC (ORIC)](/companies/oric.md) | COM | $46.8m | 1.4% | 4,319,765 |  | Unchanged |
| CRESCENT BIOPHARMA INC. | COM | $38.4m | 1.2% | 2,133,576 |  | Unchanged |
| ZURA BIO LTD | CLASS A ORD SHS | $38.0m | 1.2% | 6,434,990 |  | Unchanged |
| [ADLAI NORTYE LTD (ANL)](/companies/anl.md) | SPONSORED ADS | $36.9m | 1.1% | 3,212,731 |  | Unchanged |
| [ENLIVEN THERAPEUTICS INC (ELVN)](/companies/elvn.md) | COM | $26.7m | 0.8% | 526,331 |  | Reduced −1,200,000 |
| CYBIN INC | COM NEW | $25.5m | 0.8% | 3,851,654 |  | Unchanged |
| [CULLINAN THERAPEUTICS INC (CGEM)](/companies/cgem.md) | COM | $25.1m | 0.8% | 1,379,965 |  | Unchanged |
| [CENTURY THERAPEUTICS INC (IPSC)](/companies/ipsc.md) | COM | $21.3m | 0.6% | 8,695,652 |  | Unchanged |
| [ARTIVA BIOTHERAPEUTICS INC (ARTV)](/companies/artv.md) | COM | $19.8m | 0.6% | 2,043,596 |  | Added +434,027 |
| [CYTOMX THERAPEUTICS INC (CTMX)](/companies/ctmx.md) | COM | $18.7m | 0.6% | 4,982,124 |  | Reduced −5,000,000 |
| [ACHIEVE LIFE SCIENCE INC (ACHV)](/companies/achv.md) | COM | $18.0m | 0.5% | 2,751,032 |  | New +2,751,032 |
| [PARABILIS MEDICINES INC (PBLS)](/companies/pbls.md) | COM | $17.1m | 0.5% | 625,000 |  | New +625,000 |
| [SURROZEN INC (SRZN)](/companies/srzn.md) | COM NEW | $16.4m | 0.5% | 632,931 |  | Unchanged |
| [KORRO BIO INC (KRRO)](/companies/krro.md) | COM | $13.3m | 0.4% | 1,009,500 |  | Unchanged |
| [ALTO NEUROSCIENCE INC (ANRO)](/companies/anro.md) | COM SHS | $13.2m | 0.4% | 500,000 |  | Unchanged |
| [X4 PHARMACEUTICALS INC (XFOR)](/companies/xfor.md) | COM NEW | $9.0m | 0.3% | 1,934,253 |  | Added +1,603,728 |
| RESEARCH ALLIANCE CORP III | ORD SHS CL A | $3.2m | <0.1% | 300,000 |  | New +300,000 |
| [INMED PHARMACEUTICALS INC (INM)](/companies/inm.md) | COM NEW | $50.7k | <0.1% | 32,685 |  | New +32,685 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| ENGENE HOLDINGS INC | COM | $0 | 0.0% | 0 |  | Sold out −4,771,414 |
| KALVISTA PHARMACEUTICALS INC | COM | $0 | 0.0% | 0 |  | Sold out −6,474,485 |
| [SEPTERNA INC (SEPN)](/companies/sepn.md) | COM | $0 | 0.0% | 0 |  | Sold out −506,056 |
| [TENAX THERAPEUTICS INC (TENX)](/companies/tenx.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −1,675,262 |

Source: SEC EDGAR, Form 13F-HR, accession 0001615982-26-000015. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.